The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus

The impact of sacubitril/valsartan on outcome in patients suffering from heart failure with a concomitant diabetes mellitus

Abstract Background Guidelines classify sacubitril/valsartan as a significant part of medical treatment of heart failure with reduced ejection fraction (HFrEF). Data have shown that the HbA1c levels in patients with diabetes mellitus could be impacted by sacubitril/valsartan. A possible positive eff...

Full description

Bibliographic Details
Main Authors: Ibrahim El‐Battrawy, Jonathan Demmer, Mohammad Abumayyaleh, Carina Crack, Christina Pilsinger, Xiaobo Zhou, Andreas Mügge, Ibrahim Akin, Assem Aweimer
Format: Article
Language:English
Published: Wiley 2023-04-01
Series:ESC Heart Failure
Subjects:
Life‐threatening arrhythmia
Sacubitril/valsartan
Sudden cardiac death
Diabetes mellitus
Online Access:https://doi.org/10.1002/ehf2.14239

Internet

https://doi.org/10.1002/ehf2.14239

Similar Items